CLECTA GMBH
Desconocido
BOB: Business Opportunities in Biotech Innovation Associate to leverage cell free synthetic biology
CLECTA GMBH
tramitó un
H2020:
H2020-INNOSUP-2018-2020
The main objective of BOB is to hire and integrate a highly-committed candidate to build up an innovation strategy at c-LEcta to valorize it...
2019-08-19 - 2020-09-14 | Financiado
2019-08-19 - 2020-09-14 | Financiado
SHIKIFACTORY100: Modular cell factories for the production of 100 compounds from the shikimate pathway
CLECTA GMBH
participó en un
H2020:
H2020-NMBP-TR-IND-2018-2020
Chemical synthesis is often difficult and may be subject to unclear mechanisms, frequently producing undesired by-products, while the comple...
2018-12-12 - 2023-06-30 | Financiado
2018-12-12 - 2023-06-30 | Financiado
PlugBioIn: Plug and play enzymes for an accelerated uptake of Biocatalysis in the Pharmaceutical Industry
CLECTA GMBH
tramitó un
H2020:
H2020-SMEInst-2014-2015
At present there is a mismatch between the extensive interest of the pharmaceutical industry to utilize enzyme technology in their productio...
2015-06-18 - 2017-06-30 | Financiado
2015-06-18 - 2017-06-30 | Financiado
ROBOX: Expanding the industrial use of Robust Oxidative Biocatalysts for the conversion and production of a...
CLECTA GMBH
participó en un
H2020:
H2020-BIOTEC-2014-2015
Oxygen functionalities are key functional groups in many of today’s chemicals and materials. The efficient introduction of oxygen-functional...
2015-02-11 - 2019-03-31 | Financiado
2015-02-11 - 2019-03-31 | Financiado
BIOLEDGE: BIO knowLEDGe Extractor and Modeller for Protein Production
CLECTA GMBH
participó en un
FP7:
Better bioinformatics tools are needed to capitalize on vast amounts of data becoming accessible in biotechnology applications. The theme of...
Financiado
Financiado
NEMO: Novel high performance enzymes and micro organisms for conversion of lignocellulosic biomass to bioe...
CLECTA GMBH
participó en un
FP7:
The NEMO project provides novel efficient enzymes and microbes for 2nd generation bioethanol production. It generates through metabolic engi...
Financiado
Financiado
BIOINTENSE: Mastering bioprocess Integration and intensification across scales
CLECTA GMBH
participó en un
FP7:
BIOINTENSE is directed at addressing the challenges of low productivity and process intensity frequently hampering the implementation of bio...
Financiado
Financiado
PHARMASEA: Increasing Value and Flow in the Marine Biodiscovery Pipeline
CLECTA GMBH
participó en un
FP7:
The PharmaSea project focuses on obstacles in marine biodiscovery research, development and commercialization and brings together a broad in...
Financiado
Financiado
SUSY: Sucrose Synthase as Cost Effective Mediator of Glycosylation Reactions
CLECTA GMBH
participó en un
FP7:
Glycosyl transferases (GT) are extremely efficient biocatalysts that can be used for the synthesis of special carbohydrates and glycoconjuga...
Financiado
Financiado
ENDETECH: ENzymatic DEcontamination TECHnology
CLECTA GMBH
participó en un
FP7:
Human activities are associated with increasing amounts of waste that ultimately find their ways into European waters and have negative cons...
Financiado
Financiado
* No se disponen de datos de la empresa actual.